FDAClass IIMay 13, 2026

QUCARE Total Cholesterol in vitro diagnostic test recall

QUCARE Total Cholesterol in vitro diagnostic test REF: 6407

Why was QUCARE Total Cholesterol in vitro diagnostic test recalled?

The devices were distributed without required FDA premarket clearance or approval.

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

UDI: 08806141303060/ Lot: BS032501, BS042502, BS062501, BS062502, BS082501

Product
QUCARE Total Cholesterol in vitro diagnostic test REF: 6407
Recalling firm
DFI Co., Ltd.
Quantity
6398 units
Distribution
Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.
Recall date
May 13, 2026
Classification
Class II
Status
Ongoing
Agency
FDA (device)
Open FDA enforcement record Latest recalls